Whereas the anti-inflammatory activity of IDO may hamper immune control of M. tuberculosis replication due to decreased proliferation of M. tuberculosis antigen-specific T cells (Mehra et al., 2013; Gautam et al., 2018), it may also be beneficial under conditions where mortality is driven by excessive inflammation, such as TB-IRIS. This evidence concerns the gene IDO1 and tuberculosis.